Nanoform Finland (STU:4YL) ROCE %: -29.02% (As of Mar. 2026)


STU:4YL Nanoform Finland PLC STU:4YL
67 GF Score
Price €0.77
GF Value €1.77
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Nanoform Finland ROCE %?

Nanoform Finland STU:4YL -5.84% 67 ROCE % is -29.02% as of Mar. 2026. GuruFocus rates STU:4YL with a GF Score™ of 67/100 and a GF Value™ of €1.77 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nanoform Finland's annualized ROCE % for the quarter that ended in Mar. 2026 was -29.02%.

Nanoform Finland  (STU:4YL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nanoform Finland ROCE % Related Terms

Nanoform Finland ROCE % Historical Data

* Premium members only.

The historical data trend for Nanoform Finland's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanoform Finland ROCE % Chart

Nanoform Finland Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.98 -23.70 -25.08 -34.21 -31.77

Nanoform Finland Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.91 -39.90 -36.04 -13.93 -29.02
STU:4YL
67GF Score
Nanoform Finland PLC STU:4YL
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanoform Finland ROCE % Calculation

Nanoform Finland's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-17.826/( ( (71.806 - 7.409) + (53.976 - 6.146) )/ 2 )
=-17.826/( (64.397+47.83)/ 2 )
=-17.826/56.1135
=-31.77 %

Nanoform Finland's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-13.436/( ( (53.976 - 6.146) + (50.708 - 5.932) )/ 2 )
=-13.436/( ( 47.83 + 44.776 )/ 2 )
=-13.436/46.303
=-29.02 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -29.02% mean?
Nanoform Finland (STU:4YL) has a ROCE % of -29.02% as of Mar. 2026.
Is Nanoform Finland's ROCE % too high?
Nanoform Finland's current ROCE % is -29.02%. Overall, Nanoform Finland has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nanoform Finland's ROCE % compare to VRTX and REGN?
Nanoform Finland's ROCE % of -29.02% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Nanoform Finland's current ROCE % is -29.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanoform Finland stock overvalued right now?
Based on GuruFocus' analysis, Nanoform Finland (STU:4YL) is currently considered Possible Value Trap. The stock's GF Value™ is €1.77, compared to a current price of €0.77 — trading 56.3% below its estimated fair value. The current ROCE % is -29.02%. Nanoform Finland's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Nanoform Finland (STU:4YL), the current ROCE % is -29.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nanoform Finland (STU:4YL) Overvalued in 2026?

Based on GuruFocus' analysis, Nanoform Finland stock appears to be undervalued. The current stock price of €0.77 is trading 56.3% below its estimated GF Value™ of €1.77. GuruFocus considers Nanoform Finland to be Possible Value Trap.

Key valuation signals for STU:4YL:

  • ROCE %: -29.02%
  • GF Value™: €1.77 vs. price of €0.77 (56.3% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the STU:4YL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nanoform Finland Business Description

Address Cultivator II, Viikinkaari 4, Helsinki, FIN, 00790
Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications. Geographically, the company generates maximum revenue from Europe, followed by the United States and other regions.
67GF Score

Get the complete analysis for STU:4YL

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.77
Price
€1.77
GF Value